Iñigo Terrén

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Atopic Dermatitis

Inflammatory Response

Top Venues

International journal of molecular sciences

Cellular & molecular immunology

BioCruces Health Research Institutes

University of Basque Country (UPV/EHU) (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

BioCruces Health Research Institutes

Spain

MSc and PhD Student :: Immunopathology Group

University of Basque Country (UPV/EHU)

Spain

BSc Student :: Faculty of Medicine and Nursing - Dept. of Immunology, Microbiology and Parasitology

Education History

University of Basque Country (UPV/EHU)

Spain

MSC :: Faculty of Science and Technology

University of Basque Country (UPV/EHU)

Spain

BSC :: Faculty of Science and Technology

Publications

Joana Vitallé, Olatz Zenarruzabeitia, Aitana Merino-Pérez, Iñigo Terrén, Ane Orrantia, Arantza Pacho de Lucas, José A Iribarren, Lucio J García-Fraile, Luz Balsalobre, Laura Amo, Belén de Andrés, Francisco Borrego
Human IgM hi CD300a + B Cells Are Circulating Marginal Zone Memory B Cells That Respond to Pneumococcal Polysaccharides and Their Frequency Is Decreased in People Living with HIV. International journal of molecular sciences 24 (18) (2023)
Ane Orrantia, Iñigo Terrén, Gabirel Astarloa-Pando, Olatz Zenarruzabeitia, Francisco Borrego
Human NK Cells in Autologous Hematopoietic Stem Cell Transplantation for Cancer Treatment. Cancers 13 (7) (2021)
Joana Vitallé, Iñigo Terrén, Ane Orrantia, Agurtzane Bilbao, Pedro M Gamboa, Francisco Borrego, Olatz Zenarruzabeitia
The Expression and Function of CD300 Molecules in the Main Players of Allergic Responses: Mast Cells, Basophils and Eosinophils. International journal of molecular sciences 21 (9) (2020)
Joana Vitallé, Iñigo Terrén, Ane Orrantia, Raquel Pérez-Garay, Francesc Vidal, José A Iribarren, Carmen Rodríguez, Ana M López Lirola, Enrique Bernal, Olatz Zenarruzabeitia, Francisco Borrego
CD300a inhibits CD16-mediated NK cell effector functions in HIV-1-infected patients. Cellular & molecular immunology 16 (12) (2019)